SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-004900
Filing Date
2019-02-27
Accepted
2019-02-27 16:10:32
Documents
3
Period of Report
2019-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctmx-8k_20181231.htm 8-K 31851
2 EX-99.1 ctmx-ex991_8.htm EX-99.1 275341
3 GRAPHIC gwbdlffwawuv000001.jpg GRAPHIC 2469
  Complete submission text file 0001564590-19-004900.txt   311882
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 19637775
SIC: 2834 Pharmaceutical Preparations